Recently, inhibitors of anti-apoptotic proteins gained attention as alternative therapy target, hence we tested the BCL-XL inhibitor A-1331852 against orthotopically injected glioblastoma xenografts. This evidence concerns the gene BCL2L1 and glioblastoma.